Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 48, 2008, Pages 18794-18799

  Li, Zhaoliang ^a   Boone, David ^a   Hann, Stephen R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B23; Myc; NPM; Proliferation

Indexed keywords

NUCLEOPHOSMIN;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ADP-RIBOSYLATION FACTORS; ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FIBROBLASTS; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 57749116048     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806879105     Document Type: Article

References (27)

1. Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18:3004-3016.
2. Oster SK, Ho CS, Soucie EL, Penn LZ (2002) The myc oncogene: MarvelouslY Complex. Adv Cancer Res 84:81-154.
3. Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6:493-505.
4. Li J, Sejas DP, Burma S, Chen DJ, Pang Q (2007) Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability. Carcinogenesis 28:1163-1170.
5. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4:529-533.
6. Li J, Zhang X, Sejas DP, Pang Q (2005) Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Leuk Res 29:1415-1423.
7. Bertwistle D, Sherr CJ (2007) Regulation of the Arf tumor suppressor in Eμ-Myc transgenic mice: Longitudinal study of Myc-induced lymphomagenesis. Blood 109:792-794.
8. Qi Y, et al. (2004) p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431:712-717.
9. Dang CV, O'Donnell KA, Juopperi T (2005) The great MYC escape in tumorigenesis. Cancer Cell 8:177-178.
10. Eilers M, Picard D, Yamamoto KR, Bishop JM (1989) Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66-68.
11. Evan GI, et al. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
12. Pelengaris S, Littlewood T, Khan M, Elia G, Evan G (1999) Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3:565-577.
13. Knoepfler PS, et al. (2006) Myc influences global chromatin structure. EMBO J 25:2723-2734.
14. Cowling VH, Cole MD (2006) Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 16:242-252.
15. Naoe T, Suzuki T, Kiyoi H, Urano T (2006) Nucleophosmin: A versatile molecule associated with hematological malignancies. Cancer Sci 97:963-969.
16. Gjerset RA (2006) DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer. J Mol Histol 37:239-251.
17. Grisendi S, et al. (2005) Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437:147-153.
18. Colombo E, et al. (2005) Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol 25:8874-8886.
19. Wu MH, Chang JH, Yung BY (2002) Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: Enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression. Carcinogenesis 23:93-100.
20. Korgaonkar C, et al. (2005) Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 25:1258-1271.
21. Arabi A, Rustum C, Hallberg E, Wright AP (2003) Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J Cell Sci 116:1707-1717.
22. Grandori C, et al. (2005) c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7:311-318.
23. Sherr CJ (2001) The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2:731-737.
24. Gregory MA, Qi Y, Hann SR (2005) The ARF tumor suppressor: Keeping Myc on a leash. Cell Cycle 4:249-252.
25. Zeller KI, et al. (2001) Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J Biol Chem 276:48285-48291.
26. Gregory MA, Qi Y, Hann SR (2003) Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278:51606-51612.
27. Izumi H, et al. (2001) Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J Cell Sci 114:1533-1544.